Status:
COMPLETED
Low-level Laser Therapy for Genitourinary Syndromes and Stress Urinary Incontinence
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Vaginal Atrophy
Urinary Incontinence,Stress
Eligibility:
FEMALE
20-80 years
Brief Summary
Genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) are common for women. Low-level laser therapy (LLLT) was applied for wound healing, but there was no study regarding tre...
Detailed Description
Between September 2022 and August 2023, all women who received LLLT for GSM and SUI at the gynecologic outpatient clinic of a hospital were retrospectively reviewed. The treatment was once a week for ...
Eligibility Criteria
Inclusion
- women with GSM and SUI
- Received LLLT at the gynecologic outpatient clinic
Exclusion
- More or equal to stage 2 pelvic organ prolapse defined by pelvic organ prolapse-quantification system
- Ongoing urinary tract infection or vaginitis with the pathogen in the previous 2 weeks
- Bladder calculus
- Neurogenic bladder due to radical hysterectomy or injury of the central nervous system
- A preexisting malignant pelvic tumor.
Key Trial Info
Start Date :
September 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 14 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT06136975
Start Date
September 30 2022
End Date
August 14 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pei-chi Wu
Taipei, Taiwan, 100